跳至主要内容
临床试验/NL-OMON51377
NL-OMON51377招募中不适用

OPtimal stEnt deployment stRategy oF Contemporary sTents - PERFECT PSP

Albert Schweitzer Ziekenhuis0 个研究点目标入组 247 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
247

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Stable angina patients or acute coronary syndrome patients with bystander
  • stable coronary artery disease
  • 2. With one or more significant epicardial stenosis in native coronary arteries
  • suitable for direct stenting, according to the judgement of treating operator.
  • The use of fractional flow reserve (FFR) or resting indices like iFR and RFR to
  • assess lesion severity is encouraged.
  • 3. Subject must be at least 18 years of age
  • 4. Written consent to participate in the study

排除标准

  • 1. Lesions not suitable for direct stenting, like (sub)-total stenosis,
  • severely calcified lesions
  • 2. Culprit lesions of acute coronary syndrome cannot be randomized to the
  • trial. After successful treatment of the ACS culprit lesion, patients however
  • can be randomized in the trial in case of remaining stable non-culprit lesions
  • that thought to be stented directly of during a staged procedure.
  • 3. Lesions not suitable for OCT catheter delivery and imaging, e.g. left main
  • or ostial right coronary artery stenosis, lesions in coronary bypass grafts or
  • tortuous anatomy
  • 4. Treatment for in-stent restenosis
  • 5. Bifurcation lesions in which a two-stent technique or a proximal
  • postdilatation is planned.
  • 6. Treatment of coronary artery bypass grafts
  • 7. Creatine Clearance <= 30 ml/min/1.73 m2 (as calculated by MDRD formula for
  • estimated GFR)
  • 8. Known hypersensitivity or allergy for cobalt chromium
  • 9. Known comorbidity associated with a life expectancy < 1 year
  • 10. Unable to understand and follow study-related instructions or unable to
  • comply with study protocol
  • 11. Known comorbidity associated with a life expectancy < 1 year

研究者

相似试验